Received May 11, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (UNKNOWN)) | UNKNOWN MANUFACTURER | UNK | — | — |
pain in her sternum; pain in her ribs; felt shocky again. Hands were tingly at night as well as her left leg; electrical shocking sensation in her legs; Initial information received on 24-Apr-2026 regarding an unsolicited valid non-serious case received from a patient. This case involves a 39-year-old female patient who experienced electrical shocking sensation in her legs, felt shocky again with hands were tingly at night as well as her left leg, pain in her sternum and pain in her ribs after receiving NVX-COV2705 (OMICRON JN.1) adjuvanted vaccine (Nuvaxovid). The patient's past medical history, medical treatment(s), vaccination(s), and family history were not provided. In Nov-2025, the patient received dose 1 of NVX-COV2705 (OMICRON JN.1) adjuvanted vaccine dispersion for injection (batch/expiry: asked but unknown) (strength: unknown) via unknown route in an unknown administration site for immunization (Immunisation). On 23-Apr-2026, the patient received dose 2 dose of NVX-COV2705 (OMICRON JN.1) adjuvanted vaccine dispersion for injection (batch/expiry: asked but unknown) (strength: unknown) via unknown route in an unknown administration site for immunization (Immunisation). In 2025, the patient experienced electrical shocking sensation in her legs (Electric shock sensation, onset: 2025, latency: unknown). On 23-Apr-2026, the patient felt shocky again with hands were tingly at night as well as her left leg (Paraesthesia, latency: unknown). The patient experienced pain in her sternum (Chest pain, onset: unknown, latency: unknown) and pain in her ribs (Musculoskeletal chest pain, onset: unknown, latency: unknown). Action taken: unknown. Corrective treatment: not reported. Event outcome: unknown for electric shock sensation, chest pain and musculoskeletal chest pain; not recovered/not resolved/ongoing for paraesthesia. Initial information received on 24-Apr-2026 regarding an unsolicited valid non-serious case received from a patient. This case involves a 39-year-old female patient who experienced electrical shocking sensation in her legs, felt shocky again with hands were tingly at night as well as her left leg, pain in her sternum and pain in her ribs after receiving NVX-COV2705 (OMICRON JN.1) adjuvanted vaccine (Nuvaxovid). The patient's past medical history, medical treatment(s), vaccination(s), and family history were not provided. In Nov-2025, the patient received dose 1 of NVX-COV2705 (OMICRON JN.1) adjuvanted vaccine dispersion for injection (batch/expiry: asked but unknown) (strength: unknown) via unknown route in an unknown administration site for immunization (Immunisation). On 23-Apr-2026, the patient received dose 2 dose of NVX-COV2705 (OMICRON JN.1) adjuvanted vaccine dispersion for injection (batch/expiry: asked but unknown) (strength: unknown) via unknown route in an unknown administration site for immunization (Immunisation). In 2025, the patient experienced electrical shocking sensation in her legs (Electric shock sensation, onset: 2025, latency: unknown). On 23-Apr-2026, the patient felt shocky again with hands were tingly at night as well as her left leg (Paraesthesia, latency: unknown). The patient experienced pain in her sternum (Chest pain, onset: unknown, latency: unknown) and pain in her ribs (Musculoskeletal chest pain, onset: unknown, latency: unknown). Action taken: unknown. Corrective treatment: not reported. Event outcome: unknown for electric shock sensation, chest pain and musculoskeletal chest pain; not recovered/not resolved/ongoing for paraesthesia.
Comments: NONE